bosulif
pfizer europe ma eeig - bosutinibi (monohydraattina) - leukemia, myeloidi - antineoplastic agents, protein kinase inhibitors - bosulif on tarkoitettu aikuisille potilaille, joilla on:hiljattain diagnosoitu kroonisen vaiheen (cp) philadelphia-kromosomi-positiivinen krooninen myelooinen leukemia (ph+ kml). cp, akseleraatiovaiheen (ap), ja blastikriisivaiheen (bp) ph+ kml on aikaisemmin hoidettu yksi tai useampi tyrosiinikinaasin estäjä(s) [tki(s)] ja joille imatinibin, nilotinibin ja dasatinibin ei katsota asianmukaista hoitoa vaihtoehtoja.
dasatinib accord
accord healthcare s.l.u. - dasatinibin - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastiset aineet - dasatinib accord is indicated for the treatment of adult patients with:• ph+ acute lymphoblastic leukaemia (all) with resistance or intolerance to prior therapy. dasatinib accord is indicated for the treatment of paediatric patients with:• newly diagnosed ph+ all in combination with chemotherapy.
dasatinib accordpharma
accord healthcare s.l.u. - dasatinibin - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastiset aineet - dasatinib accordpharma is indicated for the treatment of adult patients with: newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase. chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib. ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy. dasatinib accordpharma is indicated for the treatment of paediatric patients with: newly diagnosed ph+ cml in chronic phase (ph+ cml-cp) or ph+ cml-cp resistant or intolerant to prior therapy including imatinib. newly diagnosed ph+ all in combination with chemotherapy.
dasatinib ratiopharm 20 mg tabletti, kalvopäällysteinen
teva b.v. - dasatinibi monohydricum - tabletti, kalvopäällysteinen - 20 mg - dasatinibi
dasatinib ratiopharm 50 mg tabletti, kalvopäällysteinen
teva b.v. - dasatinibi monohydricum - tabletti, kalvopäällysteinen - 50 mg - dasatinibi
dasatinib ratiopharm 70 mg tabletti, kalvopäällysteinen
teva b.v. - dasatinibi monohydricum - tabletti, kalvopäällysteinen - 70 mg - dasatinibi
dasatinib ratiopharm 80 mg tabletti, kalvopäällysteinen
teva b.v. - dasatinibi monohydricum - tabletti, kalvopäällysteinen - 80 mg - dasatinibi
dasatinib ratiopharm 100 mg tabletti, kalvopäällysteinen
teva b.v. - dasatinibi monohydricum - tabletti, kalvopäällysteinen - 100 mg - dasatinibi
dasatinib stada 20 mg tabletti, kalvopäällysteinen
stada arzneimittel ag - dasatinib - tabletti, kalvopäällysteinen - 20 mg - dasatinibi
dasatinib stada 50 mg tabletti, kalvopäällysteinen
stada arzneimittel ag - dasatinib - tabletti, kalvopäällysteinen - 50 mg - dasatinibi